84.88 USD
↘ 0.52 (0.61%)AT CLOSE (03:59 PM EDT)
Dianthus Therapeutics, Inc. Common Stock
DNTHNASDAQ • USD
84.93
↗ 0.05 (0.05%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
84.93
↗ 0.05 (0.05%)
Market: OPEN
Dianthus Therapeutics, Inc. Common Stock (DNTH) trades at $84.93 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 7, 2026.
Open?$84.60
High?$86.61
Low?$84.13
Prev. Close?$85.40
Volume?562.5K
Avg. Volume?806.9K
VWAP?$85.46
Rel. Volume?0.70x
Bid / Ask
Bid?$29.02 × 100
Ask?$144.92 × 100
Spread?$115.90
Midpoint?$86.97
Valuation & Ratios
Market Cap?4.8B
Shares Out?54.8M
Float?51.2M
Float %?93.7%
P/E Ratio?N/A
P/B Ratio?4.08
EPS?-$3.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Employees
92
Market Cap
4.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-09-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: 929-999-4055
NEW YORK, NY 10036
Phone: 929-999-4055
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?100
Momentum?48
Short Sent.?39
Piotroski F-Score?2/9Weak
Altman Z-Score?69.26Safe
Confidence?55%Low
Short InterestVery High
Short % of Float?17.24%High
Short Interest?8.8M
Days to Cover?14.4
Free Float51.2M
Avg Daily Volume612.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?26.10Strong
Quick Ratio?26.10Strong
Cash Ratio?3.21Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.08FAIR▾
Peers100
S&P44
P/S?2,508.82HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-21.4CHEAP▾
S&P97
EV/Sales?2,450.76HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-16.4%WEAK▾
S&P8
ROA?-15.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-155709000
Enterprise Value?$4.7B
Fundamentals ratios updated end of day